Four-Drug attack on Tough-to-Treat blood cancer
Disease control
Recruiting now
This study is testing a new combination of four medications for people whose multiple myeloma has come back or stopped responding to prior treatments. The main goal is to see if this combination can shrink the cancer so effectively that it becomes undetectable by very sensitive t…
Phase: PHASE2 • Sponsor: Benjamin T Diamond, MD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC